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ABSTRACT 
Objective: This study assessed the effects of alpha-mangostin (AM) and citronella oil (CO) working alone or in combination against 
Propionibacterium acnes (P. acnes) and Staphylococcus aureus (S. aureus). 
Methods: The screening for antibacterial activity of AM and CO against P. acnes and S. aureus was carried out using the disk diffusion method. The minimum 
inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of these two substances were determined using the broth microdilution 
method. The fractional inhibitory concentration indices (FICI) of a combination of AM and CO were obtained by checkerboard dilution assay. 
Results: The results showed that alpha-mangostin and citronella oil do indeed fight against P. acnes and S. aureus. The MICs and MBCs of AM against 
P. acnes and S. aureus were the same at 6.25 and 50 µg/ml, respectively. Both the MIC and the MBC of CO against P. acnes were 27.81µg/ml. The MIC 
and the MBC of CO against S. aureus were 112.13 and 224.25 µg/ml, respectively. The FICI of a combination of AM and CO against P. acnes and S. 
aureus were 2.00, indicating indifferent interaction with no additional inhibitory effect. 
Conclusion: AM and CO are very effective against P. acnes and S. aureus, nevertheless their effect when used together was indifferent from using 
alone. Further research may find that either or both of these substances combined with yet a different natural agent could provide synergy againstP. 
acnes and S. aureus. 
Keywords: Alpha-mangostin, Citronella oil, Fractional inhibitory concentration index (FICI), Propionibacterium acnes (P. acnes), Staphylococcus 
aureus (S. aureus), Anti-acne 




This study quantitatively analyzed alpha-mangostin (AM), from 
mangosteens, and citronella oil (CO), from citronella grass, to 
investigate possible synergistic effects of AM combined with CO 
against the bacteria that cause acne. 
Acne vulgaris is a very common chronic inflammatory disease of the 
pilosebaceous follicles of the skin which is caused by hyperactive 
sebaceous glands, hyperkeratosis in the hair infundibulum, P. acnes 
colonization or other bacterial infections. This disease is 
characterized by both inflammatory and non-inflammatory lesions 
[1–3]. People of all races and ages get acne, but it is most common in 
teenagers and young adults. Quality of life is often reduced for 
patients who suffer from acne vulgaris [4]. Thiboutot et al. (2009) 
reported that acne vulgaris can so disruptive as to sometimes even 
lead to serious psychiatric issues [5].  
P. acnes and S. aureus, which are gram-positive bacteria naturally 
occurring on the skin surface [6], are often what cause the 
development of acne. Excessive production and secretion of sebum 
in conjunction with hyperkeratosis in the hair infundibulum result 
in narrowed and blocked hair follicle pores, causing an increase in 
the population of P. acnes. Subsequently P. acnes proliferation, it can 
induce the production of inflammatory mediators, which are 
accountable for the inflammation, redness, and pain associated with 
acne breakouts [7, 8]. In addition, S. aureus can cause skin infections 
and exacerbate pimples and abscesses [9].  
Current treatment for acne depends on types and severity of the 
disease. Normally, patients with moderate to severe infections are 
treated with topical drugs, which include topical antibiotics and 
topical retinoids. Unfortunately those drugs often causes adverse 
side effects, such as skin irritation, dry flaky skin, itching, and 
erythema [10]. At the same time, there are numerous published 
studies on natural extracts and essential oils that are derived from 
plants and used instead of antibiotic drugs for treatment of acne. 
The current study investigated and combined two such natural 
substances, AM and CO, with the hypothesis that this mixture might 
produce a synergistic effect that enhances their activity, while at the 
same time causing fewer adverse side effects than conventional 
treatments. AM is a major constituent of the pericarp of mangosteen 
fruit, and it shows promising antibacterial activity against P. acnes 
and S. aureus [11, 12]. AM has also been found to possess anti-
inflammatory and antioxidant properties [13]. Reassuringly, a study 
by Larson et al. (2010) investigated the toxicity of AM against young 
rats and found that it did not demonstrate any adverse effects, even 
at a high doses of 80 mg/kg [14]. Moreover, a study by Sakagami et 
al. (2005) found a synergistic effect when AM isolated from the stem 
bark of Garcinia mangostana was combined with vancomycin 
hydrochloride against methicillin resistant Staphylococcus aureus 
(MRSA) [15]. There are also preliminary published studies on the 
biological activities of essential oils obtained from the leaves and 
stems of Cymbopogon nardus (Citronella grass). This grass is widely 
used as a fragrant herb in Asian cooking, and also as a medicinal 
herb due to its inhibitory effects against a variety of bacteria [16, 
17]. Citronella grass is also easy to grow, widely available, and 
inexpensive to purchase. The U. S. Environmental Protection Agency 
(1997) reported that citronella oils have a relatively low acute skin 
toxicity (LD50>2000 mg/kg) [18]. Furthermore, a study by Afsar et 
al. (2017) investigated antibacterial efficacy of creams and gels 
containing the extracts from Cassia fistula, Ficusreligiosa, 
Milletiapinnataand Wendlandiathyrsoidea in a combination with 
citronella oil at various concentrations against P. acnes and S. 
epidermidis and found that all the formulations displayed 
antibacterial activity against the selected strains [19]. Although 
there have been previous studies of AM or CO used individually or 
used in combination with other antibacterial substances, the current 
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study is believed to be the first to look for possible synergistic 
benefits from using these two substances together. 
MATERIALS AND METHODS 
Test substances and chemical reagents 
Alpha-mangostin was obtained from Chroma Dex Inc., Santa Ana, CA. 
Citronella oil was purchased from Thai-China Flavours and 
Fragrances Industry Co., Ltd., Bangkok, Thailand. Geraniol was 
purchased from Sigma-Aldrich, Inc., Steinheim, Germany. The 
solvents and other chemicals were analytical grade.  
Quantitative analysis of AM and geraniol 
The purity of AM was tested using high performance liquid 
chromatography (HPLC) analysis as per Pothitirat et al.’s method, 
somewhat modified [20]. The AM was dissolved at six different 
concentrations ranging from 0.25 to 50 μg/ml. These six solutions 
were separated using a Vertisep C-18 column (5 μm, 4.6 x 250 mm) 
and a guard column. Acetonitrile and 0.2% o-phosphoric acid in 
water were mixed at a ratio of 9:1 (v/v), and this solution was used 
as the mobile phase. The mobile phase flow rate was set at 1 ml/min 
with a UV detection wavelength of 320 nm. In order to determine 
the calibration curve, the resulting HPLC chromatogram data was 
plotted in a graph showing peak area versus concentration. 
The geraniol content of the CO was determined using gas 
chromatography–flame ionization detection (GC-FID) analysis as per 
Jumepaeng et al.’s method, somewhat modified [19]. The geraniol 
was dissolved at six different concentrations ranging from 62.5 to 
2,000 μg/ml. These six solution were separated using an HP-5 
column (0.25 mm, 30m x 0.25 mm), using split injection mode 7:1 at 
240 °C. Helium was the carrier gas at a flow rate of 2 ml/min. The 
oven temperature was initially at 50 °C for 2 min, then gradually 
increased to 150 °C, with the heat increase at a rate of 5 °C/min, and 
finally increased to 240 °C at a rate of 10 °C/min. The temperature 
was held at 240 °C for 2 min. The amount of geraniol in the CO was 
calculated using a calibration curve. 
Test organisms 
The antibacterial activity of AM and citronella oil were evaluated 
using the two bacteria types that are considered to be the main 
cause of acne. P. acnes DMST 14916 and S. aureus ATCC 25923 were 
obtained from the Department of Medical Sciences, Naresuan 
University, Thailand.  
Inoculum preparation 
The inocula were prepared using the direct colony suspension 
method as described by the Clinical and Laboratory Standards 
Institute (CLSI) guidelines [21]. P. acnes was cultivated on brain 
heart infusion agar (BHI) for 72 h under anaerobic conditions at 
37±2 °C, and S. aureus was cultivated on nutrient agar (NA) for 24 h 
under aerobic conditions, also at 37±2 °C. The inoculum of each 
bacteria strain was prepared by the direct colony suspension as 
recommended by the CLSI.  
Screening for antibacterial activity of AM and CO 
AM and CO were tested against P. acnes and S. aureus using the agar 
disk diffusion method of A. Klančnik et al. (2010) [22] with some 
modifications. First, test disks were prepared in advance by placing 
20 µl of test solution (a broth medium solution containing 100 
mg/ml of either AM or CO, along with 0.5% Tween 80 as co-solvent) 
onto the center of a sterile filter-paper disk (6 mm in diameter). The 
standard commercially prepared disks of clindamycin (2 µg/disk) 
were used as a positive control. 
Next, for each of the two inocula, the bacterial suspension was 
swabbed over the surface BHI agar for P. acnes and Müller-Hinton 
agar (MHA) for S. aureus. The plates were allowed to dry for 5 min. 
The prepared test disks were then placed on the agar surfaces, and 
the plates were incubated under the previously described culture 
conditions for the respective bacteria. Finally, the inhibition zone 
diameters of each plate were measured in millimeters. Each test was 
repeated in triplicate. 
Determination of MIC and MBC of AM and CO  
The MICs of AM and CO alone were determined by using 2,3,5,-
triphenyltetrazolium chloride (TTC) as a chromogenic marker, based on 
the method of Athikomkulchai et al. (2008) with some modifications 
[23]. Two sets of eight test solutions were prepared containing AM at 
various concentrations ranging from 1.56 to 200 µg/ml, along with 1% 
DMSO and 0.5% Tween 80. The first set was in BHI media broth for 
testing on the P. acnes. The second set was in Müller-Hinton broth 
(MHB) for testing on the S. aureus. Similarly, two sets of eight CO test 
solutions ranging from 3.50 to 448.5 µg/ml were also prepared in the 
same way. These AM solutions and CO solutions were prepared by serial 
two-fold dilution with their respective broths in 96-well plates. Two 
growth controls were set up, one containing P. acnes in its medium and 
the other containing S. aureus in its medium. Clindamycin was used as a 
positive control, while negative controls were the media contained 1% 
DMSO and 0.5% Tween 80.  
After incubation, 20 µl of TTC solution (20 mg/ml) was added to all 
the plates, which were then all incubated at 37±2 °C for 3 h. If the 
TTC in the plates encounters bacteria cells that are still viable, those 
viable cells convert the colorless TTC to red formazan, with the color 
intensity proportional to the amount of viable cells, i.e. the more 
viable cells there are, the darker the red color. The color changes 
were evaluated visually. The lowest concentrations of AM and CO 
that showed no visible growth of bacteria or no red color were 
recorded as their respective MIC values. The MBCs of AM and CO 
were then determined by subculturing from the well broth used for 
the MIC test onto agar plates and incubated under the respective 
conditions used earlier to make each of the two inocula. The 
concentration of AM or CO required to kill all the bacteria were 
recorded as their respective MBC values.  
Determination of synergistic activity from a combination of AM 
and CO  
Synergistic activity of the combination of AM and CO was determined by 
the checkerboard dilution assay using the method of Thathaisong and 
Sangnual (2011) with some modifications [24]. Fresh new stock 
solutions of AM and CO were prepared. The respective MICs of AM and 
CO were used together to define a fractional inhibitory concentration 
(FIC) of 1. Then dilutions of each agent’s FIC were prepared in a series of 
0xMIC, 0.25xMIC, 0.50xMIC, 0.75xMIC and 1xMIC in a 96 well-plate. 
Then, the bacterial inoculum was added and all the plates were then 
incubated under the respective conditions used. The FIC index (FICI) 
was determined according to the following equation (1): 











Where [A] = MIC of AM combined with CO 
[B] = MIC of CO combined with AM 
MICA
MIC
 = MIC of AM alone 
B
A FICI ≤ 0.5 indicates synergy, 0.5 ≤ FICI ≤ 1 indicates addition, 1 ≤ 
FICI ≤ 4 indicates indifference, and FICI ≤ 4 indicates antagonism. 
 = MIC of CO alone 
Statistical analysis 
All tests were performed in triplicate, and the resulting data is presented 
here as mean±standard deviation (SD) of the three experiments. 
RESULTS 
Quantitative analysis of AM and geraniol  
The purity of the AM powder used in this study was tested by HPLC 
analysis at 320 nm. The calibration curve of AM in concentration in the 
range of 0.25-50 µg/ml showed a good linear relationship with a 
correlation coefficient (r2) of 0.9999. HPLC chromatograms of AM 
showed a retention time at 8.2 min. The purity of AM was found to be 
95%. Next the geraniol content of the CO used in this study was 
determined by GC-FID analysis. The calibration curve of geraniol within 
the concentration range of 62.5-2,000 µg/ml showed a good linear 
relationship with an r2 of 0.9998. GC-FID chromatograms of CO showed 
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a retention time at 2.9 min. The geraniol content of the CO was found to 
be 25%. 
Screening antibacterial activities of AM and CO 
The antibacterial activity of AM and CO against P. acnes and S. 
aureus were determined by the disk diffusion method. 
Clindamycin was used as a positive control. The results are shown 
in table 1, where they are displayed in the average zone of 
inhibition (mm) including the disk diameter (6 mm). The zones of 
inhibition of Clindamycin against P. acnes and S. aureus were 
50.0±0.50 and 20.5±0.50 mm, respectively, and the zones of 
inhibition of AM against P. acnes and S. aureus were 10.5±1.25 and 
8.5±1.00 mm, respectively. Meanwhile, CO exhibited larger zone 
sizes of 18.3±1.00 mm and 15.9±1.25 mm. 
  
Table 1: Antibacterial activity of AM and CO against P. acnes and S. aureus 
Substance tested Average zone of inhibition (mm) 
P. acnes S. aureus 
AM (2 mg/disk) 10.5±1.25 8.5±1.00 
CO (2 mg/disk) 18.3±1.00 15.9±1.25 
Clindamycin* (2 µg/disk)  50.0±0.50 26.5±0.50 
 *positive reference standard, mean±SD; n=3 
 
Determination of MIC and MBC values of AM and CO 
The MIC and MBC of AM, CO and clindamycin against P. acnes and S. 
aureus are shown in table 2. When the positive control clindamycin 
was tested against P. acnes, both the MIC and MBC values of 
clindamycin were 0.16 µg/ml. In comparison, both the MIC and MBC 
values of AM against P. acnes were 6.25 µg/ml. CO did not perform 
as well, with MIC and MBC values of 27.81 µg/ml.  
Against S. aureus, both the MIC and MBC values of clindamycin were 
0.63 µg/ml. AM again performed better than CO, with AM’s MIC and 
MBC values at 50 µg/ml, while CO had an MIC value of 112.13 µg/ml 
and an MBC value of 224.25 µg/ml. 
Determination of synergistic activity of a combination of AM 
and CO  
The synergistic effects of a combination of AM and CO against P. 
acnes and S. aureus were tested using the checkerboard method, and 
the FICI results of this combination are reported in table 3. The FICI 
values against both bacteria were 2, indicating a test interpretation 
of “Indifferent with no additional inhibitory effect”. 
  
Table 2: The MIC and MBC values of AM and CO against P. acnes and S. aureus 
Substance tested P. acnes S. aureus 
MIC MBC MIC MBC 
AM (µg/ml) 6.25 6.25 50 50 
CO (µg/ml) 27.81 27.81 112.13 224.25 
Clindamycin* (µg/ml) 0.16 0.16 0.63 0.63 
 *positive reference standard, n=3 
 
Table 3: MICs, FICs and FICIs of a combination of AM and CO against P. acnes or S. aureus 
Bacterial type Substance tested MIC(µg/ml) FIC FICI Interpretation 
Alone Combination 
P. acnes AM 6.25 6.25 1 2 Indifferent with no additional inhibitory effect 
CO 27.81 27.81 1 
S. aureus AM 50 50 1 2 Indifferent with no additional inhibitory effect 




In this study, various antibacterial properties of alpha-mangostin 
and citronella oil were tested, specifically their MIC, MBC and FICI 
values, in order to look for a synergistic effect when AM and CO were 
combined. In the disc diffusion test for screening antibacterial 
activity, AM showed a smaller inhibition zone against P. acnes and S. 
aureus than CO. Mostly the inhibition zone is related to the MIC 
value, in that usually the larger the inhibition zone, the lower the 
MIC value. However, that was not the case when comparing AM and 
CO. Although AM showed lower MIC and MBC values against these 
bacteria types than CO, but it manifested smaller inhibition zone 
than CO. One possible explanation of this uncommon result might be 
that the size of inhibition zone also depends on its ability to diffuse 
through the agar [25], which can be expressed by the partition 
coefficient (log Po/w) value. A lower log Po/w value means the 
compound is more hydrophilic and more likely to diffuse through 
agar media. The log Po/w of AM is 4.64 [26]. Unfortunately the log 
Po/w of CO has not been previously reported and is not readily 
available. Nevertheless, geraniol, known for CO’s active constituents, 
possesses a log Po/w
Looking at the FICI test results, the FICI of the combination of AM 
and CO against P. acnes and S. aureus was 2.00, indicating an 
interpretation of “indifferent with no additional inhibitory effect”, 
which means this combination did not create any synergy beyond 
the individual antibacterial abilities of the individual substances.  
 value of 2.5 [27]. As a consequent, CO may 
possess the greater diffusion ability than AM. Thus, the small zone of 
inhibition observed may not necessarily preclude better 
antibacterial activity from that substance.  
Several studies have reported that the antibacterial mechanisms of 
AM and CO against P. acnes and S. aureus are actually the same 
mechanism, namely membrane disruption. A study by Koh et al. 
(2013) reported that AM rapidly disrupts the cytoplasmic 
membrane of gram positive-bacteria, thereby causing leakage of 
intracellular content. Koh’s study hypothesizes that AM’s main 
antibacterial activity comes from its isoprenyl groups, which are 
driven by hydrophobic interaction. In order to reduce free energy, 
the phenyl ring of the isoprenyl group embeds itself into the 
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hydrophobic region of the bacteria’s membrane. This results in the 
membrane damage, thereby increasing penetration of AM [12]. 
Similarly, Khunkitti et al. (2010) reported that the main components 
of CO are monoterpene alcohols, including citronellal, geraniol, and 
citronellol. These compounds variously dehydrate and/or denature 
membrane proteins of gram positive-bacteria, causing damage to the 
cytoplasmic membranes and cell walls. Then the cells lose their rigid 
structures, leading to morphological changes, intercellular leakage, 
and cell lysis. In this way, the compounds inhibit or kill the bacteria 
cells. Moreover, Khunkitti reported that CO’s activity against 
bacteria was greater than that of any of its major components in 
isolation, due to synergistic effects of multiple components [16].  
It is unfortunate that no synergistic effect was found when AM and 
CO were combined to counter P. acnes and S. aureus. Even though, it 
could be used together as there is no antagonist interaction 
observed. In this verity, another possible avenue for future research 
might be to combine either AM or CO alone with one of the 
pharmaceutical acne treatments, and investigate if that sort of 
combination will yield a synergistic effect. Such a combination might 
exhibit considering synergy, since the mechanism of AM or CO and 
the mechanism of the pharmaceutical drug will probably be 
different. 
CONCLUSION 
The two natural substances alpha-mangostin and citronella oil are 
good candidates for the development of anti-acne products. 
However, using them in combination may not have substantial 
benefit as it was indifferent from using alone, so at least for now 
they might better considered independent antibacterial agents and 
used as such in natural products for the treatment of acne. 
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